{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:47:38Z","timestamp":1790707658111,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.autrev.2024.103720","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T16:30:16Z","timestamp":1733589016000},"page":"103720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Sarah","family":"Bencardino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo Simone","family":"Matichecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Fanizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Della-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103720_bb0005","doi-asserted-by":"crossref","first-page":"m1067","DOI":"10.1136\/bmj.m1067","article-title":"Advances in the diagnosis and management of IgG4 related disease","volume":"369","author":"Lanzillotta","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2024.103720_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cei.12641","article-title":"Immunology of IgG4-related disease","volume":"181","author":"Della-Torre","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103720_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/TCRM.S99985","article-title":"IgG4-related disease: current challenges and future prospects","volume":"12","author":"Lang","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.autrev.2024.103720_bb0020","first-page":"1181","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.autrev.2024.103720_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103720_bb0030","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.gastrohep.2019.08.009","article-title":"Review of IgG4-related disease","volume":"42","author":"S\u00e1nchez-Oro","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2024.103720_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-021-00529-y","article-title":"IgG4-related diseases of the digestive tract","volume":"19","author":"L\u00f6hr","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2024.103720_bb0040","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s10620-010-1287-1","article-title":"IgG4-related sclerosing disease: a novel mimic of inflammatory bowel disease","volume":"55","author":"Narula","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2024.103720_bb0045","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ueg2.12319","article-title":"Environmental risk factors for inflammatory bowel disease","volume":"10","author":"Singh","year":"2022","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.autrev.2024.103720_bb0050","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103720_bb0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2024.103720_bb0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10620-014-3350-9","article-title":"Environmental risk factors for inflammatory bowel diseases: a review","volume":"60","author":"Ananthakrishnan","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2024.103720_bb0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4274\/balkanmedj.2018.0809","article-title":"The clinicopathologic spectrum of IgG4-related disease","volume":"35","author":"Obiorah","year":"2018","journal-title":"Balk Med J"},{"key":"10.1016\/j.autrev.2024.103720_bb0070","doi-asserted-by":"crossref","first-page":"2250007","DOI":"10.1002\/eji.202250007","article-title":"Regulatory T cells as a therapeutic approach for inflammatory bowel disease","volume":"53","author":"Laukova","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2024.103720_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14397595.2019.1650694","article-title":"Pathogenesis of IgG4-related disease. Comparison with Sj\u00f6gren\u2019s syndrome","volume":"30","author":"Tsuboi","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2024.103720_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: Pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.autrev.2024.103720_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5217\/ir.2018.16.1.26","article-title":"Immunological pathogenesis of inflammatory bowel disease","volume":"16","author":"Lee","year":"2018","journal-title":"Intest Res"},{"key":"10.1016\/j.autrev.2024.103720_bb0090","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/lary.23429","article-title":"Roles of IL-17, Th1, and Tc1 cells in patients with IgG4-related sclerosing sialadenitis","volume":"122","author":"Ohta","year":"2012","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.autrev.2024.103720_bb0095","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/gutjnl-2023-329963","article-title":"Fibrosis in IBD: from pathogenesis to therapeutic targets","volume":"73","author":"Rieder","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2024.103720_bb0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2024.103720_bb0105","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.autrev.2024.103720_bb0110","article-title":"European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations","volume":"8","author":"Jm","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.autrev.2024.103720_bb0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14218\/JTG.2024.00017","article-title":"Fecal, blood, and urinary biomarkers in inflammatory bowel diseases","volume":"2","author":"Bencardino","year":"2024","journal-title":"J Transl Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103720_bb0120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cca.2020.08.025","article-title":"Calprotectin in inflammatory bowel disease","volume":"510","author":"Khaki-Khatibi","year":"2020","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.autrev.2024.103720_bb0125","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: useful, magic, or unnecessary toys?","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2024.103720_bb0130","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/602809","article-title":"Pathologies associated with serum IgG4 elevation","volume":"2012","author":"Ebbo","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103720_bb0135","article-title":"Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice","volume":"2012","author":"Ryu","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103720_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103720_bb0145","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2024.103720_bb0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"10.1016\/j.autrev.2024.103720_bb0155","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/PAS.0b013e3182495c96","article-title":"IgG4-related sclerosing disease of the small bowel presenting as necrotizing mesenteric arteritis and a solitary jejunal ulcer","volume":"36","author":"Wong","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2024.103720_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/medicina60010057","article-title":"Immunoglobulin G4-related disease of the intestine: a clinicopathological entity to be considered","volume":"60","author":"Vernia","year":"2024","journal-title":"Medicina (Mex)"},{"key":"10.1016\/j.autrev.2024.103720_bb0165","first-page":"4537","article-title":"IgG4+ plasma cell infiltration is correlated with the development of inflammatory bowel disease and can be regulated by TLR-4","volume":"11","author":"Chen","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.autrev.2024.103720_bb0170","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1038\/s41598-018-28397-8","article-title":"High level of IgG4 as a biomarker for a new subset of inflammatory bowel disease","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2024.103720_bb0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5114\/ceh.2019.89119","article-title":"IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis","volume":"5","author":"Farahmand","year":"2019","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.autrev.2024.103720_bb0180","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3748\/wjg.14.3948","article-title":"IgG4-related sclerosing disease","volume":"14","author":"Kamisawa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103720_bb0185","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/ibd\/izaa230","article-title":"Serum IgG4 subclass deficiency defines a distinct, commonly encountered, severe inflammatory bowel disease subtype","volume":"27","author":"Koutroumpakis","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2024.103720_bb0190","first-page":"817","article-title":"Immunoglobulin G4 (IgG4)-associated pouchitis - Part of IgG4 related disease? A case series and review of the literature","volume":"48","author":"Bilal","year":"2016","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.autrev.2024.103720_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox091","article-title":"IgG4-related disease involving the esophagus: a clinicopathological study","volume":"30","author":"Obiorah","year":"2017","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"key":"10.1016\/j.autrev.2024.103720_bb0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00535-017-1420-4","article-title":"Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey","volume":"53","author":"Notohara","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103720_bb0205","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5152\/tjg.2014.5714","article-title":"The prevalence of IgG4-positive plasma cell infiltrates in inflammatory bowel disease patients without autoimmune pancreatitis","volume":"25","author":"Topal","year":"2014","journal-title":"Turk J Gastroenterol Off J Turk Soc Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103720_bb0210","first-page":"423","article-title":"Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease","volume":"36","author":"Chase","year":"2023","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103720_bb0215","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/17434440.2023.2283166","article-title":"Recent advances in the use of ultrasound in Crohn\u2019s disease","volume":"20","author":"Barchi","year":"2023","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.autrev.2024.103720_bb0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ueg2.12069","article-title":"International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases","volume":"9","author":"D\u2019Amico","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.autrev.2024.103720_bb0225","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","article-title":"Long-term evolution of disease behavior of Crohn\u2019s disease","volume":"8","author":"Cosnes","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2024.103720_bb0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14218\/JTG.2023.00096","article-title":"Endoscopic treatment approaches for inflammatory bowel diseases: old friends and new weapons","volume":"2","author":"Barchi","year":"2024","journal-title":"J Transl Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103720_bb0235","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2024.103720_bb0240","doi-asserted-by":"crossref","DOI":"10.1007\/s00535-024-02130-x","article-title":"Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment\u2014insights from Phase II and III trials","author":"Massironi","year":"2024","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.autrev.2024.103720_bb0245","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.3390\/jcm12155014","article-title":"Efficacy and safety of S1P1 receptor modulator drugs for patients with moderate-to-severe ulcerative colitis","volume":"12","author":"Bencardino","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2024.103720_bb0250","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/gut.2010.225482","article-title":"Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis","volume":"60","author":"Leiper","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2024.103720_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1388940","article-title":"Case report and review of literature: IgG4-gastroduodenitis in upper GI Crohn\u2019s disease: two separate entities or just a marker of disease severity?","author":"Desmedt","year":"2024","journal-title":"Front Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T02:22:43Z","timestamp":1738462963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1568997224002118"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103720","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103720"}}